Faster Delivery
We mobilize in days, not weeks, so you stay ahead in live deals
We are an AI-native healthcare market research & consulting firm delivering expert-validated insights.
We partner with Private Equity firms, Investment Banks and Healthcare Corporates to solve complex challenges, accelerate decision-making, and unlock growth opportunities.
We combine deep healthcare expertise, AI-powered intelligence, and a global expert network to deliver sharper insights, faster diligence, and stronger strategic decisions.
Explore further →Trusted by Leading Investors &
Healthcare Organizations
Our Services
Commercial Due Diligence (CDD)
We help investors validate growth potential through TAM/SAM analysis, customer insights, competitive benchmarking, key purchase criteria (KPC), switching cost assessment, GTM evaluation, and commercial risk identification to support informed investment decisions
M&A Advisory
We support investors and acquirers in sourcing and evaluating platform and add-on targets through target identification, market mapping, confidential outreach to gauge seller interest, and transaction support
Corporate Strategy Consulting
We help organizations unlock growth through market share expansion, geographic diversification, adjacent market entry, pricing strategy, channel optimization, competitive benchmarking, and customer insights
Market Research Reports
Comprehensive off-the-shelf healthcare and life sciences market research reports featuring accurate market sizing, market growth forecasting, country-level & regional analysis, competitive landscape benchmarking, technology & regulatory trend assessment, and actionable strategic insights to support strategic planning, market entry decisions, and business growth initiatives
Primary Research
We conduct expert-validated primary research, clinician, operator, customer, and procurement interviews, to answer targeted market questions fast, standalone or as an input to a larger engagement
Why Clients Choose Us?
Lower Advisory Spend
Clients typically save $100K–$400K per engagement while making decisions with 2x greater confidence
Experts
More Value Created – insights informed by rigorous analysis & firmly grounded in market reality
Deep sector expertise helps identify opportunities that unlock measurable upside
Insights & >11k
KOL Access
3x Faster, Smarter Decisions
AI-led research + broad KOL access enable faster diligence, stronger decisions, and better outcomes
Our Track Record
We help businesses grow through focused strategy, expert guidance, and practical solutions designed to deliver measurable and lasting results.
What Our Clients Say
“Medi-Tech Insights delivered exceptional market intelligence that helped us validate our investment thesis and identify key growth opportunities. Their healthcare expertise is unmatched."
Managing Director
Leading Private Equity Firm (AUM $15 bn)
“Medi-Tech Insights’ diligence and KOL insights provided us with a clear understanding of market dynamics and competitive landscape. Their work was instrumental in our due diligence process."
Vice President
Global Investment Firm (AUM >$5 bn)
“Medi-Tech Insights is our go-to partner for quality research and actionable insights. They are responsive, collaborative, and consistently exceed expectations."
Head of Strategy
Pharma Company (Revenues >$1 bn)
“I compared what Medi-Tech Insights mentioned 2 years ago in the report and most of it was accurate even in a fast-moving market…"
Investment Director
Mid-sized PE Firm (AUM <$1 bn)
“The level of granular analysis done by Medi-Tech Insights was unparalleled and something none of our previous vendors had done… "
Managing Partner
Mid-Market Private Equity Investor (AUM >$1bn)
Recently Published Reports
Global Bioconjugation Market Size & Trends Report Segmented by Product and Service (Reagen...
Bioconjugation Market is projected to grow at ~13% CAGR by 2031, driven by rising demand for targeted therapeutics, biot...
Global Generative AI in Healthcare Market Size & Trends Report Segmented by Application (D...
Generative AI in healthcare market is on the rise, expected to grow at 32% CAGR, driven by advancements in technology an...
Global Nuclear Medicine Market Size & Trends Report Segmented by Product (SPECT, PET, Alph...
The global nuclear medicine market is projected to grow at a 12% CAGR, fueled by advancements in imaging and radiopharma...
Referenced by
Let’s Discuss Your
Next Transaction
Talk to our healthcare specialists about your next investment, strategy or market intelligence need.
Let’s Connect